The Immune Response to Stroke

Recruiting now

Conditions studied: Stroke, Acute, Dementia

In brief

Some patients develop cognitive decline after a stroke, but we don't always understand the mechanisms. It has been proposed that a proportion of the patients develop an autoimmune immune response, and that this could potentially explain the cognitive decline in some of the patients. The current study aims to investigate this hypothesis in a subgroup of patients with stroke.

Key facts

Study ID

NCT05277129

Run by

University of Oslo

People needed

40

Starts

2021-06-24

Expected to finish

2029-06-06

Last updated by the study team

2022-03-14

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Stroke < 72 h
• Age > 18 years

You may not qualify if…

• Brain hemorrhage verified by CT or MRI scan
• Previous or present immunological disease or other serious comorbidity
• Ongoing immune respons after infection or vaccination < 1 month
• Cognitive without ability to understand and/or give an informed consent to participate in the study

Where it is running

• Akershus University Hospital — Lørenskog, Norway (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.